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Hypertension resulting from macrovascular disturbance as defined according to CBP is a risk factor for morbidity and mortality in elderly adults. 2 The current study examined whether CBP or HBP provided stronger predictive power for outcomes by comparing events in elderly and younger adults with T2DM with hypertension or normotension over 10 years.
Subjects comprised 400 Japanese individuals with T2DM divided into two groups: elderly (≥65) and younger (<65). 3 All-cause morbidity and mortality were obtained for all subjects, along with the National Glycohemoglobin Standardization Program (NGSP) value for glycosylated hemoglobin (HbA1c) in accordance with Japan Diabetes Society recommendations. 4, 5 Initially, 329 individuals were treated with hypoglycemic drugs, mixed insulin, or both for T2DM, and 196 were treated with antihypertensive drugs for hypertension. This study was a registered clinical trial (Clinical Trial registration No. NCT00760110).
Nonfasting chemical laboratory tests were performed at each clinic visit. Clinical laboratory specimens were assessed for blood HbA1c, serum creatinine, serum lipids, and urinary albumin excretion rate. 1, 6 Blood pressure (BP) was measured as previously described. 1 Hypertension was defined as systolic BP of 130 mmHg or greater and normotension as systolic BP less than 130 mmHg. 1, 7 Microvascular complications included nephropathy, neuropathy, and retinopathy.
1 Macrovascular complications included cerebrovascular disease (CVD), coronary heart disease (CHD), and peripheral arterial obstruction. 1 
STUDY OUTCOMES
The primary end-point was death, 1 and secondary endpoints were improved or new and worsened micro-and macrovascular events. 1 
Statistical Analysis

Clinical Characteristics at Baseline and End of Study
All results are presented as means AE standard deviations. Means were compared using the Student t-test. Prevalence of micro-and macrovascular complications or medical treatments according to age group and hypertensive status were compared at baseline and end-points using CBP or HBP. 1 Relationships were calculated using Pearson correlations.
End of Study and Outcome Measures
Differences in primary and secondary outcomes according to age group and hypertension determined using CBP or HBP were assessed using Kaplan-Meier survival estimates and compared according to hazard ratios using the logrank test.
Statistical Package version 6.67 (ComWorks, Tokyo, Japan) was used for analysis, and two-tailed P < .05 was considered statistically significant.
RESULTS
Clinical characteristics of 225 elderly and 175 younger subjects with T2DM were determined. A significant (P < .001) positive correlation was seen between systolic HBP at baseline and age in all subjects.
Outcomes
Primary Outcome
Mean survival in the elderly group was 83 AE 159 months (range 1.5-120 months). Primary outcomes were seen in 71 subjects, comprising 30 with cancer, 19 with CVD, 11 with CHD, six with respiratory disease, and five with other diseases. Death and hazard ratios using HBP at endpoint in the elderly group assessed using Kaplan-Meier analysis were significantly higher in subjects with hypertension than in those with normotension, whereas no significant differences were seen using CBP in elderly and younger groups with hypertension and normotension.
Secondary Outcomes
Mean survival in the elderly group related to microvascular events was 92 AE 284 months (range 0-120 months) and related to macrovascular events was 84 AE 101 months (range 2-120 months). Using HBP at the end of the study in the elderly group, micro-and macrovascular events and hazard ratios determined using Kaplan-Meier analysis were significantly higher in subjects with hypertension than in those with normotension, whereas no significant differences using CBP were seen in the elderly or younger groups with hypertension or normotension.
DISCUSSION
Recent guidelines recommend that the threshold BP should be 5-10 mmHg lower in HBP than CBP. [8] [9] [10] In this study, the same normotension threshold was used with CBP and HBP. Nevertheless, using HBP, risk of death was significantly higher in the elderly group than in the younger group, although death is also common among the elderly using CBP measurement. 2 The highly significant relationship between HBP at baseline and age in all subjects may support this view.
All of the findings from this study indicated that incidences of death and micro-and macrovascular complications were significantly greater in the elderly than the younger subjects. Earlier identification of hypertension in elderly adults using HBP could be added to a list of risk factors in individuals with T2DM. 1 
CHANGES IN DESCRIPTIVE TERMS FOR OLDER PEOPLE IN THE MEDICAL LITERATURE OVER THE LAST 65 YEARS
To the Editor: In 2007, Falconer and O'Neill recommended that medical journals use "older" to describe older people instead of "the old," "aged," and in particular, "elderly".
1 They noted that "elderly" is among the leastpopular choices in surveys of older people themselves, 2, 3 may be conflated with the concept of frailty, and carries negative and pejorative connotations. Spies and Claassen disagreed, noting that, "Even if one preferred word were found, it would be a matter of time before this new term would carry the stigma of the old one". 4 A previous study of how older people are described in the medical literature reported that "elderly" was the most widely used term overall but was restricted to eight general medical and gerontological journals from 1996 to 2006. 5 We extended this study to the English-language medical literature from 1950 to 2015.
PubMed was used to search titles and abstracts of the clinical English-language literature from 1950 to 2015 for use of any of "geriatric," "aged," "old," "older," and "elderly" as adjectives following the term "frail" or preceding the terms "patient(s)," "person(s)," "individual(s)," "adult(s)," "man," "woman," "men," "women," "people," or "population." In the relevant searches, we excluded "care of/for the elderly" (which seemed more likely to be used to describe services for older people rather than older people themselves), "year-old" "young-old," "old-old," "oldest-old," and "middle aged." "Aged," "elderly," and "old" can also be used as nouns to describe older people in general, as in "the aged." Hence, we also searched for "the aged," "the elderly," and "the old." A random sample of 50 abstracts using each phrase from each 5-year period (650 in total for each) was read to determine the proportion that met the criterion of a noun usage referring to older people in general (rather than, for example, "the aged kidney" or "the old paradigm"), to apply an appropriate correction to the yearly totals.
Use of any of our target words or phrases in a title or abstract increased from 45 in 1950 to 10,333 in 2015. For "the elderly," 647 (99.5%) of the 650 references checked referred to older people, and no correction was applied when adding "the elderly" to the specified adjectival uses of elderly. In contrast, only 48.3% of "the aged" and 15.6% of "the old" in the references checked concerned older people, and so, for example, the total for aged in each year included all adjectival uses and 48.3% of uses of "the aged." Figure 1 shows the trends in the use of different terms with time. "Aged" was the most popular term from 1950 to 1961 but declined to 3.4% of references to older people in 2015. "Geriatric" was relatively common (more than 10% of references) from 1955 to 1976
